Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosomal binding domain 2 pseudogene 7 (HMGN2P7)
- Target
- HMGN2P7
- Molecular classification
- Pseudogene, Other (non-coding RNA, non-functional protein, noncoding DNA)
01
Overview
HMGN2P7 (high mobility group nucleosomal binding domain 2 pseudogene 7) is a human pseudogene identified in genome annotations as a non-functional genomic sequence sharing similarity with the coding gene HMGN2, which encodes a nucleosome-binding protein. As a pseudogene, HMGN2P7 is predicted not to encode a functional protein, and it is currently not associated with any known biological function, disease, or drug interaction. Its main recognized role is as a genomic relic with potential to regulate gene expression only in principle, based on what is known for other pseudogenes, but no such specific regulatory function is assigned to HMGN2P7 in curated databases or peer-reviewed literature.
- Other names
- HMGN2L7
02
Mechanism of action
Not applicable—no drugs target this pseudogene.
03
Biological functions
Potential competitive endogenous RNA (ceRNA) effects on gene regulation are hypothesized for some pseudogenes, but there is no specific evidence that HMGN2P7 itself performs such a function.In general, pseudogenes may regulate their parent gene transcript by competing for regulatory elements or acting as decoys for microRNAs (miRNAs), but HMGN2P7 has no direct assignment to such roles in indexed databases or the literature.No confirmed direct biological function for HMGN2P7.
04
Disease associations
No known direct disease association.Some pseudogenes are reported to act as molecular sponges or gene regulators with relevance to cancer and other diseases, but there is no evidence that HMGN2P7 is involved.
Beyond the preview
Go deeper on High mobility group nucleosomal binding domain 2 pseudogene 7 (HMGN2P7).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 7 (HMGN2P7).